Effects of Dexmedetomidine on Regulating Endotoxin-Induced Up-Regulation of Inflammatory Molecules in Murine Macrophages

Journal of Surgical Research

Volumn 154, Issue 2, 2009, Pages 212-219

  Lai, Yen Chun ^a,b   Tsai, Pei Shan ^c   Huang, Chun Jen ^a,b,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 adrenergic receptors; COX 2; cytokine; dexmedetomidine; endotoxin; iNOS

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; CYTOKINE; DEXMEDETOMIDINE; IDAZOXAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; YOHIMBINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; CYTOKINES; DEXMEDETOMIDINE; DINOPROSTONE; ENDOTOXEMIA; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; UP-REGULATION;

EID: 67349257928     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.010     Document Type: Article

References (25)

1. Edgington T.S., Mackman N., Fan S.T., et al. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol 34 Suppl (1992) S15
2. Hierholzer C., Menezes J.M., Ungeheuer A., et al. A nitric oxide scavenger protects against pulmonary inflammation following hemorrhagic shock. Shock 17 (2002) 98
3. Futaki N., Takahashi S., Kitagawa T., et al. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo. Inflamm Res 46 (1997) 496
4. Morse D., Pischke S.E., Zhou Z., et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2786 (2003) 36993
5. Coursin D.B., Coursin D.B., and Maccioli G.A. Dexmedetomidine. Curr Opin Crit Care 7 (2001) 221
6. Khan Z.P., Ferguson C.N., and Jones R.M. α-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54 (1999) 146
7. Taniguchi T., Kidani Y., Kanakura H., et al. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 32 (2004) 1322
8. Huang Y.H., Tsai P.S., Kai Y.F., et al. Lidocaine inhibition of inducible nitric oxide synthase and cationic amino acid transporter-2 transcription in activated murine macrophages may involve voltage-sensitive na+ channel. Anesth Analg 102 (2006) 1739
9. Ebert T.J., Hall J.E., Barney J.A., et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382
10. Chen Y., Zhao Z., Code W.E., et al. A correlation between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg 91 (2000) 353
11. Feinstein D.L., Reis D.J., and Regunathan S. Inhibition of astroglial nitric oxide synthase type 2 expression by idazoxan. Mol Pharmacol 55 (1999) 304
12. Fornai M., Blandizzi C., Colucci R., et al. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice. Gut 54 (2005) 608
13. Chow J.C., Young D.W., Golenbock D.T., et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 (1999) 10689
14. Blackwell T.S., and Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17 (1997) 3
15. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268 (1993) 14553
16. Lymperopoulos A., Karkoulias G., Koch W.J., et al. Alpha2-adrenergic receptor subtype-specific activation of NF-kappaB in PC12 cells. Neurosci Lett 402 (2006) 210
17. Ziolo M.T., Katoh H., and Bers D.M. Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104 (2001) 2961
18. van der Voort R., Kavelaars A., van de Pol M., et al. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha(1)-adrenergic receptors. J Neuroimmunol 108 (2000) 82
19. Forstermann U., Closs E.I., Pollock J.S., et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23 (1994) 1121
20. Vulliemoz Y., Shen H., and Virag L. α-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain. Anesthesiology 85 (1996) 544
21. Hieble J.P., and Ruffolo Jr. R.R. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors. Ann NY Acad Sci USA 763 (1995) 8
22. Regunathan S., Feinstein D.L., and Reis D.J. Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved?. Ann NY Acad Sci USA 881 (1999) 410
23. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine versus lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 298 (2007) 2644
24. Mason K.P., Zurakowski D., Zgleszewski S.E., et al. A. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 18 (2008) 403
25. Bylund D.B. Subtypes of α1- and α2-adrenergic receptors. FASEB J 6 (1992) 832